News
First, he landed his role in "Modern Family," a critically acclaimed ABC sitcom that went on for 11 seasons and catapulted ...
Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.
Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than ...
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong ...
As a recent mass shooting has left many on a journey toward healing, FSU and FAMU are gearing up for a celebration of pomp ...
Shares of Eli Lilly fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed ...
Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.
The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.
During a conversation with senior writer @EdEastonJr, Philadelphia Eagles legend Brian Dawkins reflects on the Rose Parade and Brandon Graham's career ...
Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) ...
Orforglipron, an experimental treatment Eli Lilly is developing for diabetes and weight loss, hit high marks in the first of several pivotal trials. The daily tablet produced blood-sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results